Photronics, Inc. (PLAB)
NASDAQ: PLAB · Real-Time Price · USD
50.16
+0.68 (1.37%)
At close: May 1, 2026, 4:00 PM EDT
49.93
-0.23 (-0.46%)
After-hours: May 1, 2026, 7:49 PM EDT

Photronics Earnings Call Transcripts

Fiscal Year 2026

Fiscal Year 2025

  • Q4 revenue rose 3% sequentially to $216 million, led by record high-end IC sales and strong U.S. demand. Gross and operating margins exceeded expectations, and strategic expansions in the U.S. and Korea are set to drive future growth. Fiscal 2026 CapEx is planned at $330 million.

  • Operating cash flow and margins have improved significantly, driven by industry consolidation, pricing power, and expansion in the US and Asia. Investments target advanced nodes and geographic diversification, with growth expected from increased outsourcing and rising photomask values.

  • Q3 revenue was $210M, flat year-over-year, with strong FPD growth offsetting IC headwinds. Strategic investments in advanced nodes and geographic expansion continue, while Q4 guidance reflects cautious optimism amid ongoing geopolitical risks.

  • Global operations and strategic U.S. presence position the company for growth as semiconductor reshoring accelerates and advanced display technologies roll out. Recent years saw margin expansion and strong cash flow, with ongoing investments in capacity and technology.

  • Second-quarter revenue was $211 million, flat sequentially and down 3% year-over-year, with high-end IC and advanced mask technologies outperforming amid ongoing weakness in mainstream segments. Leadership transitioned to George Macricostas as CEO, and $72 million was spent on share repurchases.

  • Photronics reported a slight revenue decline in 2024 amid sluggish demand but maintained strong cash flow and improved margins. Strategic investments target U.S. growth as global chip production diversifies, while China remains a key market despite rising competition.

  • Q1 revenue was $212M, with non-GAAP EPS of $0.52 above guidance and strong cash flow. High-end IC and FPD segments showed resilience, while mainstream IC faced weakness. Cautious 2025 outlook due to macro and geopolitical risks.

  • Photomask manufacturing revenue has surged in China and margins have expanded to 37% in Q4 2024, supported by high-end business growth and strategic U.S. investments. The company is increasing CapEx to $200 million in 2025, focusing on regionalization and maintaining a strong cash position.

Fiscal Year 2024

Fiscal Year 2023

Fiscal Year 2022

Fiscal Year 2021

Fiscal Year 2020

Fiscal Year 2019

Fiscal Year 2018

Powered by